Zhejiang Huaye Plastics Machinery
301616
Alnera Aluminium
301613
Glory View Technology
301396
Guangzhou Sie Consulting
300687
Tibet Duo Rui Pharmaceutical
301075
CN Stock MarketDetailed Quotes
300832 ShenZhen New Industries Biomedical Engineering
- 58.22
- +0.11+0.19%
Market Closed Mar 31 15:00 CST
45.74BMarket Cap24.72P/E (TTM)
58.44High57.47Low32.81KlotVolume57.86Open58.11Pre Close190.51MTurnover0.48%Turnover Ratio27.66P/E (Static)785.72MShares97.2052wk High5.63P/B39.60BFloat Cap57.2552wk Low69.73Limit Up680.21MShs Float104.59Historical High46.49Limit Down1.67%Amplitude16.21Historical Low1.00Dividend TTM58.07Avg Price12.71KlotAsk1.72%Div YieldTTM100Lot Size18.86KlotBid
ShenZhen New Industries Biomedical Engineering News
ShenZhen New Industries Biomedical Engineering (300832.SZ) has received IVDR CE certification for multiple products.
ShenZhen New Industries Biomedical Engineering (300832.SZ) announced that 73 of its products have been certified by the EU notification body - TÜV SÜD...
Shenzhen New Industries Biomedical Engineering (SZSE:300832) Is Reinvesting To Multiply In Value
Vivo announced the establishment of a Siasun Robot&Automation Lab, focusing on incubating the "brain" and "eyes" of robots, primarily targeting the Consumer market.
Sina Technology News, on the afternoon of March 25, during the Boao Forum for Asia Annual Conference 2025, as a member of the Boao Forum Advisory Council and a strategic partner for four consecutive years, vivo showcased its latest technological achievements, including its blue technology matrix, vivo mixed reality headset, and advancements in the 6G field at the Boao venue. During the "Release Moment" segment held on the afternoon of the 25th, Hu Baishan, Executive Vice President, Chief Operating Officer of vivo, and Director of the vivo Central Research Institute delivered a keynote speech titled "Technology as a Tool, Humanism as a Path." In the speech, Hu Baishan mentioned that the mobile phone industry is a reflection of China's Technology innovation, and vivo is at the forefront.
On March 11, A-share investment warning needle | Guanggang Gas: Shareholder Jinggangshan Chuanxing plans to reduce its Shareholding by no more than 2%; HengFeng Information Technology: No revenue has been formed within the scope of the "DeepSeek", "AI Asi
Shareholders of ShenZhen New Industries Biomedical Engineering, Sequoia Capital, plan to reduce their stake by no more than 1%; shareholders of Guanggang Gas, Jinggangshan Chengxing, plan to reduce their stake by no more than 2%; Beijing Jingcheng Machinery Electric stated that the sales revenue from hydrogen-related products is expected to account for about 4.22% of the company's main Business revenue from January to September 2024; Hl Corp (Shenzhen) does not have any major matters such as mergers, acquisitions, or reorganizations related to general Siasun Robot&Automation in the planning stage; Jiangsu Jingyuan Environmental Protection Co.,Ltd. stated that Cloud Computing-related Business comprises a relatively small proportion of the company's overall Business structure; HengFeng Information Technology has not generated operating income within the scope of the "DeepSeek", "AI Agents", and "Robot" Concept.
Gelonghui Announcement Selection | Jinhui Co., Ltd.: The net income for 2024 is 0.477 billion yuan, a year-on-year increase of 39.06%, and a proposed cash dividend of 2.20 yuan; HengFeng Information Technology: Has not generated revenue within the scope o
【Hot News】Beijing Jingcheng Machinery Electric (600860.SH): Sales revenue from hydrogen-related products accounts for approximately 4.22% of the company's main Business income from January to September 2024. Hl Corp (Shenzhen) (002105.SZ): There are no significant matters such as mergers and acquisitions or reorganizations involving general Siasun Robot&Automation that are in the planning stage. Jiangsu Jingyuan Environmental Protection Co.,Ltd. (688096.SH): Cloud Computing related business accounts for a relatively small proportion of the company's overall business structure. Xince Standards (300938.SZ): The joint venture 'Shenzhen Xince Standards Robot Technology Co., Ltd.' is still in the establishment process. HengFeng Information Technology (300605.SZ): Not finalized.
Express News | New Industries Biomedical Says Major Shareholder Plans to Unload up to 1% Stake in the Company Within Three Months
Does Shenzhen New Industries Biomedical Engineering (SZSE:300832) Deserve A Spot On Your Watchlist?
ShenZhen New Industries Biomedical Engineering (300832.SZ): Hepatitis B Virus Surface Antigen Detection Kit (Magnetic Microparticle Chemiluminescence Method) has received IVDR CE certification.
ShenZhen New Industries Biomedical Engineering (300832.SZ) announced that the company's product, the Hepatitis B Virus Surface Antigen Detection Kit (magnetic micro-particle...)
ShenZhen New Industries Biomedical Engineering (300832.SZ): The company's products have obtained IVDR CE certification.
On March 4, Gelonghui announced that ShenZhen New Industries (300832.SZ) has obtained the highest risk level Class D certification for its hepatitis B virus surface antigen detection kit (magnetic microparticle chemiluminescence method) from the EU notified body - TüV Süd Group. The new EU In Vitro Diagnostic Medical Devices Regulation (IVDR, EU 2017/746) replaces the previous EU In Vitro Diagnostic Medical Devices Directive (IVDD, 98/79/EC) and governs in vitro diagnostic medical instruments in the EU market. To date, the company has accumulated 170 chemiluminescent reagent products.
EDA GROUP HLDGS plans to invest no more than 0.1 billion yuan to establish a Fund.
EDA GROUP HLDGS (02505) announced that on February 27, 2025 (after trading hours), Yinshan Investment (the company's wholly-owned indirect subsidiary) and Xizheng Fund will enter into a partnership agreement for a Fund with an initial proposed total size of 0.2 billion yuan over the next three years. The group's proposed subscribed capital contribution will not exceed 0.1 billion yuan, accounting for no more than 50% of the total subscribed capital of the Fund. The Fund will primarily invest in companies engaged in cross-border E-Commerce innovation industries that are still in their early or mid-stages. The Fund may also invest in overseas warehousing facilities and projects that have strategic significance and efficient operation capabilities.
Nomura Adjusts Shenzhen New Industries Biomedical Engineering's Price Target to 90.31 Yuan From 95.79 Yuan, Keeps at Buy
Shenzhen New Industries Biomedical Engineering Co., Ltd.'s (SZSE:300832) Stock Is Going Strong: Is the Market Following Fundamentals?
Shenzhen New Industries Biomedical Engineering Gets Two Medical Device Registration Certificates for Assay Kits
ShenZhen New Industries Biomedical Engineering (300832.SZ): Acquired 2 medical instruments registration certificates.
Gelonghui, on February 12, announced that ShenZhen New Industries Biomedical Engineering Co., Ltd. recently received two "Medical Instruments Registration Certificates" issued by the Guangdong Provincial Pharmaceutical Administration. They are the progesterone determination kit (magnetic microparticle chemiluminescence method) and the anti-glomerular basement membrane antibody IgG determination kit (magnetic microparticle chemiluminescence method).
ShenZhen New Industries Biomedical Engineering (300832.SZ): Sequoia Group has completed the Shareholding of 1% of its shares.
ShenZhen New Industries Biomedical Engineering (300832.SZ) announced that Sequoia 聚业 will be between December 30, 2024, and 2025...
Insufficient Growth At Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832) Hampers Share Price
Saudi Arabia won the right to host the 2034 World Cup, and there is no shortage of questioning voices behind the Crown Prince's big victory
Saudi Arabia confirmed the right to host the 2034 World Cup, meaning the world's biggest sporting event is returning to the Gulf region for the second time in less than a decade. Crown Prince Mohammed bin Salman hopes to boost tourism, establish influence, and improve the country's image through sporting events. Getting the right to host the World Cup is a great victory for him. Stanis Elsborg, head of Play the Game, a Danish agency that studies sports ethics standards, said, “This is of great significance to the Crown Prince himself and the Saudi government. Arguably the pinnacle of their sports strategy so far, but for Wang
If EPS Growth Is Important To You, Shenzhen New Industries Biomedical Engineering (SZSE:300832) Presents An Opportunity
Shenzhen new industries biomedical engineering (300832.SZ): has obtained the registration certificate for the complement C3 assay kit (immunoturbidimetric method) medical instruments.
Shenzhen New Industries Biomedical Engineering (300832.SZ) announced on November 26th that the company recently received a 'medical instruments registration certificate' issued by the Guangdong Pharmaceutical Supervision Administration. The product is named Complement C3 Assay Kit (immunoturbidimetry), with registration number Yue Equipment Standard 20242401551, valid from November 21, 2024, to November 20, 2029. This assay kit is used for quantitative determination of complement C3 in human serum and plasma, clinically used for auxiliary diagnosis of complement deficiencies or related immunodeficiency diseases. This certification enriches the company's biochemical testing products.
shenzhen new industries biomedical engineering (300832.SZ): Received a medical instruments registration certificate.
Gelonghui reported on November 21 that shenzhen new industries biomedical engineering (300832.SZ) announced that recently, it received a medical instruments registration certificate issued by the Guangdong Provincial Drug Administration. This is for the cyclosporine assay kit (magnetic microparticle chemiluminescence method).
